Dexamethasone 12 mg vs. 6 mg for COVID-19 Patients with Severe Hypoxia

Dexamethasone 12 mg vs. 6 mg for COVID-19 Patients with Severe Hypoxia

Among patients with COVID-19 and severe hypoxia, dexamethasone 12 mg did not result in statistically significantly more days alive without life support at 28 days than dexamethasone 6 mg. However, the confidence interval... read more

Continuous Positive Airway Pressure and Pronation Outside the ICUs in COVID-19 ARDS

Continuous Positive Airway Pressure and Pronation Outside the ICUs in COVID-19 ARDS

Continuous positive airway pressure with patient mobilization (including pronation) was effective and safe in patients with ARDS due to COVID-19 managed outside the intensive care unit setting during the pandemic. Of 90... read more

Precision Medicine and Heterogeneity of Treatment Effect in Therapies for ARDS

Precision Medicine and Heterogeneity of Treatment Effect in Therapies for ARDS

Acute respiratory distress syndrome (ARDS) is a clinically heterogenous syndrome, rather than a distinct disease. This heterogeneity at least partially explains the difficulty in studying treatments for these patients... read more

Balanced Solution vs. 0.9% Saline Solution Fluid Treatment in Critically Ill Patients

Balanced Solution vs. 0.9% Saline Solution Fluid Treatment in Critically Ill Patients

Among critically ill patients requiring fluid challenges, use of a balanced solution compared with 0.9% saline solution did not significantly reduce 90-day mortality. The findings do not support the use of this balanced... read more

Convalescent Plasma for COVID-19 in Hospitalised Patients

Convalescent Plasma for COVID-19 in Hospitalised Patients

Convalescent plasma (CP) and standard of care (SOC) did not result in a higher proportion of clinical improvement on at day 28 in hospitalised patients with COVID-19 compared to SOC alone. This is an investigator-initiated,... read more

When COVID-19 Complicates Other Diagnoses

When COVID-19 Complicates Other Diagnoses

The medical community is rapidly trying to identify complications and patterns of disease to improve patient outcomes as the COVID-19 pandemic continues. Numerous studies have shown varying degrees of liver damage in... read more

Targeting Cellular Signalling Pathways in Lung Diseases

Targeting Cellular Signalling Pathways in Lung Diseases

The book comprehensively reviews and provides detailed insight into the cellular and molecular signalling mechanisms involved in pathophysiology of various respiratory diseases, towards developing effective therapeutic strategies... read more

COVID-19 Variant Classifications and Definitions

COVID-19 Variant Classifications and Definitions

Genetic variants of SARS-CoV-2 have been emerging and circulating around the world throughout the COVID-19 pandemic. Viral mutations and variants in the United States are routinely monitored through sequence-based surveillance,... read more

Inhaled Budesonide Improves Time to COVID-19 Recovery

Inhaled Budesonide Improves Time to COVID-19 Recovery

Inhaled budesonide improves time to recovery, with a chance of also reducing hospital admissions or deaths (although our results did not meet the superiority threshold), in people with COVID-19 in the community who are at... read more

Impact of ABCDE Bundle Implementation in the ICU on Specific Patient Costs

Impact of ABCDE Bundle Implementation in the ICU on Specific Patient Costs

Full ABCDE bundle implementation resulted in a decrease in total hospital laboratory costs and total hospital laboratory and diagnostic resource utilization while leading to an increase in physical therapy costs. The full... read more

Fungal Infections Complicating COVID-19

Fungal Infections Complicating COVID-19

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread globally to pandemic proportions. Although the majority of cases have asymptomatic or mild infections,... read more

COVID-19 Variants in Patients with Immunosuppression

COVID-19 Variants in Patients with Immunosuppression

Patients with immunosuppression are at risk for prolonged infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In several case reports, investigators have indicated that multimutational SARS-CoV-2... read more

Milrinone vs. Dobutamine in the Treatment of Cardiogenic Shock

Milrinone vs. Dobutamine in the Treatment of Cardiogenic Shock

In patients with cardiogenic shock, no significant difference between Milrinone and Dobutamine was found with respect to the primary composite outcome or important secondary outcomes. A total of 192 participants (96 in... read more

The Harriet Lane Handbook: Mobile Medicine Series

The Harriet Lane Handbook: Mobile Medicine Series

Written "by residents, for residents" and reviewed by expert faculty at The Johns Hopkins Hospital, Lauren Kahl, MD and Helen K. Hughes, MD, MPH, The Harriet Lane Handbook, 21st Edition, remains your #1 source of pediatric... read more

Variations in End-of-Life Practices in ICUs Worldwide

Variations in End-of-Life Practices in ICUs Worldwide

Limitation of life-sustaining therapies is common worldwide with regional variability. Withholding treatment is more common than withdrawing treatment. Variations in type, frequency, and timing of end-of-life decisions were... read more

Red Book: Report of the Committee on Infectious Diseases

Red Book: Report of the Committee on Infectious Diseases

Extending an 8-decade tradition of excellence, Red Book® provides the most reliable and clinically useful information on the manifestations, etiology, epidemiology, diagnosis and treatment of more than 200 childhood infectious... read more

Eosinophilic Esophagitis

Eosinophilic Esophagitis

Once considered a rare condition, eosinophilic esophagitis is now one of the most common conditions diagnosed during the assessment of feeding problems in children and during the evaluation of dysphagia and food impaction... read more